Clinical Trial Update: A Phase 2 Exploratory Study of CS-3150 in Japanese Hypertensive Patients With Moderate Renal Impairment [Phase 2]

View source ↗

Summary

Phase 2 exploratory study of CS-3150 in Japanese hypertensive patients with moderate renal impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• CS-3150 (CS-3150)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Hypertension | Phase 2 | Status: COMPLETED